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Abstract
Background: Since 2000, the World Health Organization has recommended a package of interventions
to prevent malaria during pregnancy and its sequelae that includes the promotion of insecticide-treated
bed nets (ITNs), intermittent preventive treatment in pregnancy (IPTp), and effective case management of
malarial illness. It is recommended that pregnant women in malaria-endemic areas receive at least two
doses of sulphadoxine-pyrimethamine in the second and third trimesters of pregnancy. This study assessed
the prevalence of placental malaria at delivery in women during 1st or 2nd pregnancy, who did not receive
intermittent preventive treatment for malaria (IPTp) in a malaria-endemic area with high bed net coverage.
Methods: A hospital-based cross-sectional study was done in Ifakara, Tanzania, where bed net coverage
is high. Primi- and secundigravid women, who presented to the labour ward and who reported not using
IPTp were included in the study. Self-report data were collected by questionnaire; whereas neonatal birth
weight and placenta parasitaemia were measured directly at the time of delivery.
Results: Overall, 413 pregnant women were enrolled of which 91% reported to have slept under a bed
net at home the previous night, 43% reported history of fever and 62% were primigravid. Malaria parasites
were detected in 8% of the placenta samples; the geometric mean (95%CI) placental parasite density was
3,457 (1,060–11,271) parasites/μl in primigravid women and 2,178 (881–5,383) parasites/μl in
secundigravid women. Fifteen percent of newborns weighed <2,500 g at delivery. Self-reported bed net
use was statistically associated with lower risk for low birth weight [OR 0.34 (95% CI: 0.16–0.74) and OR
0.22 (95% CI: 0.08–0.59) for untreated and treated bed nets, respectively], but was not associated with
placental parasitaemia [OR 0.74 (0.21–2.68) and OR 1.64 (0.44–6.19) for untreated and treated bed nets,
respectively].
Conclusion:  The observed incidence of LBW and prevalence of placental parasitaemia at delivery
suggests that malaria remains a problem in pregnancy in this area with high bed net coverage when eligible
women do not receive IPTp. Delivery of IPTp should be emphasized at all levels of implementation to
achieve maximum community coverage.
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Background
Malaria infection during pregnancy poses substantial risks
to the mother, her fetus and the newborn. Consequences
of malaria infection during pregnancy include severe ane-
mia, placental parasitaemia and intra-uterine growth
retardation. These factors contribute to low birth weight
(LBW), one of the principal causes of infant mortality in
the African region[1]. Primigravid, in particular, and
secundigravid women are at higher risk for placental
malaria than women with multiple prior pregnancies[2].
Since 2000, the World Health Organization (WHO) has
recommended a package of interventions to prevent
malaria during pregnancy and its sequelae[3]. This
includes the promotion of ITNs, IPTp, and effective case
management of malarial illness. With respect to IPTp,
WHO recommends that pregnant women in malaria-
endemic areas receive at least two doses of sulphadoxine-
pyrimethamine in the second and third trimesters of preg-
nancy[4]. Many countries have adopted the WHO recom-
mendations, but implementation has often been
hampered by constraints within health service delivery
system or individual perceptions of IPTp[5,6]. These fac-
tors include health service delivery systems burdened by
poor drug supply, poor health worker practices and low
attendance or late presentation to antenatal clinics.
The National Malaria Control Programme (NMCP) for
mainland Tanzania adopted the WHO recommendations
for prevention of malaria in pregnancy in 2001. In the
same year, the national first line antimalarial treatment
drug was changed from chloroquine to a single dose of
sulphadoxine-pyrimethamine and this also became the
first choice drug for IPTp [7]. In 2004, during a health
facility survey in 21 districts across mainland Tanzania the
NMCP discovered that nearly 60% of pregnant women
received at least one dose of IPTp [8].
Since the mid-1990s, the Tanzania Ministry of Health
endorsed in its national guidelines the use of ITNs as a
household malaria prevention tool. Various non-govern-
mental organizations and projects have since promoted
subsidized ITN sales in the country under the direction of
the Ministry. In communities surrounding Ifakara town,
ITN promotion efforts have been underway for more than
a decade now. Net coverage surveys in the region in 1995
and 1996 revealed that 17% and 37% of households,
respectively, owned at least one bed net [9,10]. This pro-
portion increased markedly after intensive promotion of
highly subsidized ITNs. In 2004, it was recorded that
more than 80% of households in villages surrounding
Ifakara owned a bed net and/or reported using bed nets.
Moreover, the current district wide bed net coverage
including an area of moderate ITN promotion activities
stands at 78.4%[11]. The increased bed net coverage made
an important contribution to prevention of malaria ill-
ness episodes among children less than five years[12]. The
impact on other risk groups has not been studied in detail.
Whereas the impact on other groups besides children has
been under reported, this study investigated the occur-
rence of malaria in pregnant women who did not report
receiving IPTp during their pregnancy. Placental parasitae-
mia and neonatal birth weight were used as outcome indi-
cators. In particular, the study investigated the extent to
which use of bed nets contributed to protecting this group
of women from the impact of malaria in pregnancy.
Materials and methods
Study area and population
The study area included Ifakara town and the surrounding
villages in the rice growing plains of the Kilombero River
Valley. Monsoon tropical rains fall from December to May
leading to an average annual rainfall of 1,200 mm.
Malaria transmission ranges from intense to moderate
and transmission is perennial, peaking after the period of
long rains[13,14]. A hospital-based study was carried out
at St. Francis Designated District Hospital (SFDDH) in
Ifakara town, Tanzania. Ifakara town is the administrative
headquarters for Kilombero District which covers 14,900
km2 and contains more than 50 villages. SFDDH is a 400-
bed hospital with the labour ward providing services to
pregnant women from Ifakara (about 75% of attendees)
and from the surrounding villages (about 15% of attend-
ees), belonging to both Kilombero District and neighbor-
ing Ulanga District. The remaining 10% of pregnant
women come from other parts of Kilombero and Ulanga
Districts as well as other neighbouring districts within
Morogoro Region.
The population of Ifakara is about 100,000 people and
the 25 villages surrounding Ifakara have a combined pop-
ulation of another 90,000 who participate in a continuous
Demographic Surveillance System (DSS). Women of
reproductive age in the DSS account for 20% of the gen-
eral population whereby 3% of them bear a child each
year.
Recruitment procedures
A hospital based cross-sectional study included all preg-
nant women who gave consent to be interviewed during
labour. The one-year enrollment period started in Decem-
ber 2003 through to December 2004. A trained nurse
midwife interviewed all eligible women who presented
for delivery at the labour ward, using a structured ques-
tionnaire, documented delivery outcomes, and collected
placenta samples after delivery. A woman was eligible if
she was in her 1st or 2nd pregnancy and had not received
IPTp from an antenatal care provider during their recently
completed pregnancy. Pregnant women who were seri-
ously ill at the time of delivery were excluded from theMalaria Journal 2008, 7:133 http://www.malariajournal.com/content/7/1/133
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study. This study occurred alongside a randomized con-
trolled trial of three alternative regimens for IPTp which
will be reported later.
Data and sample collection
Care and admission record taking for all pregnant women
during delivery followed the normal hospital routine.
During each interview, the nurse midwife counterchecked
the information on drug use from the antenatal clinic
(ANC) cards and case management logs. In the question-
naire, information about the place of domicile, fever epi-
sodes, treatment of fever including antimalarial drug use,
and the use of bed nets during the woman's recently com-
pleted pregnancy was obtained. After delivery, a trained
nurse midwife scored the baby (Apgar score) at one
minute and five minutes later, measured the birth weight
and gestational age of the baby, and collected two blood
slides from the placenta. Thick and thin blood films were
prepared from samples collected using a round ended
plastic spatulae from incised maternal and cord parts of
the placenta. A research microscopist air-dried and stained
slides (one for back up purposes) with 10% Giemsa for 30
minutes and a study clinician randomly selected 10% of
all slides to be quality controled by a 2nd reader. Plasmo-
dium falciparum malaria parasitaemia per μl was deter-
mined by counting parasites per 200 leukocytes, assuming
8,000 leukocytes per μl. The results were made available
to all mothers before they were discharged from the hos-
pital for feedback purposes.
Data-analysis procedures
Data entry was done using FoxPro® database software ver-
sion 7 (Microsoft Corporation, Redmond USA 2001) at
the Ifakara Health Research and Development Centre
(IHRDC). Data cleaning and analysis were done using
Stata version 8.0 (Stata Corporation, College Station,
Texas USA) software. Newborn birth weight was classified
as normal (>= 2,500 g) or low (<2,500 g)[15]. Univariate
analysis was used to identify predictors of placental para-
sitaemia and low birth weight. Age, sex, fever, use of anti-
malarial drugs and management of fever, use of mosquito
bed nets, parity, and patient home were each examined in
univariate analyses. Those predictors that were significant
at the p = 0.10 level were subsequently included in a mul-
tivariate logistic regression model. In the multivariate
model, an interaction term was introduced for combina-
tions of variables that demonstrated a relevant relation-
ship with each outcome of interest. The presence of
statistical interaction in the model was tested using a like-
lihood ratio test (LRT).
Ethical consideration
This study was approved as part of the larger clinical trial
by the institutional review boards of the Centers for Dis-
ease Control and Prevention, IHRDC, and the Tanzanian
Medical Research Coordinating Committee. Eligible
women provided written informed consent before being
enrolled.
Results
Four hundred and thirteen pregnant women were
enrolled into the study upon presenting for delivery in the
labour ward. Characteristics of these women and their
newborns are given in Table 1. Primigravid women
accounted for 62% of those enrolled in the study. Three
quarters of all women were living in Ifakara or villages sur-
rounding the town. Overall net coverage was very high
with 91% of women reporting that they had slept under a
bed net at home the night prior to admission to the hos-
pital for delivery. Of these women, 23% reported that
their net was treated with insecticide within the previous
year. Of the 416 infants born to 413 enrolled women, 408
(98%) were live singleton deliveries, 6 (1.4%) were live
twin infants and 2 (0.5%) were stillborn. The overall
mean birth weight among singleton babies was 2,881 g.
The mean birth weight of the singleton newborns was
2,793 g (SD,423 g) and 3,023 g (SD,444 g) among prim-
igavid and secundigravid respectively. The mean birth
weight of singleton babies born to primigravid was signif-
icantly lower than that of those born to secundigravid
women (p < 0.01). Sixty infants (15%) among the live sin-
gleton births were classified as low birth weight.
Overall, 43% of the mothers reported to have experienced
at least one episode of illness with fever during the course
of pregnancy and 33 (8%) of the placental samples were
positive for P. falciparum (Table 1). The geometric mean
placental parasite density was 3,457 (1,060–11,271) in
primigravid women, and 2,178 (881–5,383) [95% Confi-
dence intervals, CI] parasites/μl in secundigravid women.
Among the women who reported fever (n = 178), only
58% reported self use of anti-malarial medications
whereas the remaining used antipyretics and other forms
of drugs including antibiotics (Table 2).
In univariate analyses, mother's age and the use of a bed
net were associated with placenta parasitaemia at delivery
(p = 0.09 for both) (Table 2). In the multivariate logistic
regression analysis however, neither age nor bed net use
was significantly associated with placental parasitaemia
(LR, p = 0.08).
The risk of LBW was related to the mother's age (p < 0.01),
parity (p = 0.04) and the use of a bed net (p = 0.05) (Table
3) in univariate analyses. Only the use of a bed net
remained significant in the multivariate model (p < 0.01).
There was not any evidence of interaction between age
and parity in the multivariate model that included an
interaction term (age times parity) [LRT, p = 0.07]. Bed net
users had a considerably lower risk of delivering an infantMalaria Journal 2008, 7:133 http://www.malariajournal.com/content/7/1/133
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with LBW than non-users. This protective effect was
slightly stronger for women who used treated bed nets
(OR 0.22, CI: 0.08 – 0.59) than for women who used
untreated nets (OR 0.34, CI: 0.16 – 0.74).
Discussion
This study showed that in the absence of effective IPTp
coverage some risk from malaria during pregnancy per-
sisted. Interestingly, despite the absence of IPTp, the prev-
alence of placental parasitaemia among primigravid and
secundigravid women in Ifakara has remained relatively
low. Reasons for this low prevelance may include the sub-
stantial increase in ITN coverage over the past 10 years
and the general ecological trend previously described in
Ifakara town[14]. Since the inception of the Kilombero
Valley social marketing programme for Insecticide-
Treated Bed Nets (KINET), ITN coverage in the area has
increased from 37% in 1996 to over 85% in 2005. Previ-
ous studies conducted in the same facility in 1994–95 on
malaria and pregnancy revealed placental parasitaemia
rates in women of all parity categories at 35.2% even
though some of the study population used chloroquine
for prophylaxis [15].
It can be argued that the true prevalence of placental par-
asitaemia may have been somewhat higher, because the
microscopic detection has limited sensitivity compared to
the more sensitive and more expensive approach of pla-
cental histopathology[16]. In this study, the microscopic
placental examination allowed for a simpler and quicker
analysis that provided evidence on the presence of placen-
tal malaria in women who did not receive IPTp.
Table 1: Maternal and infant's characteristics
Attribute Overall
Age mean (SD), years 20.3 (3.6)
Patient's village of residence:
Ifakara & its vicinity No. (%) 307 (74.3)
Beyond Ifakara region No. (%) 106 (25.7)
Reported to have slept under bed-net at home the night prior to admission for delivery:
Untreated No. (%) 280 (67.8)
Treated No. (%) 96 (23.2)
Total No. (%) 376 (91.0)
Reported fever episode No. (%) 178 (43)
With placenta parasitaemia No. (%) 33 (8)
Geometric (95% CI) mean placenta parasitaemia:
Primigravid mean parasites/μl 3,457 (1,060–11,271)
Secundigravid mean parasites/μl 2,178 (881–5,383)
Total number of newborn: 416
Alive singletons No. (%) 408 (98.1)
Alive twins No. (%) 6 (1.4)
Stillbirths No. (%) 2 (0.5)
Neonatal birth weight:
No. (singleton including stillbirths) 404
Birth weight mean (SD), g 2,881 (445)
Neonates sex
Male No. (%) 213 (51.2)
Female No. (%) 203 (48.8)
Incidence of LBW:
Birth weight <2500 g No. (%) 60 (14.9)
Male 29 (48.3)
Female 31 (51.7)Malaria Journal 2008, 7:133 http://www.malariajournal.com/content/7/1/133
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This study recorded a 15% incidence of LBW and the risk
of delivering a LBW infant was lower in mothers who used
a bed net (either treated or untreated). Moreover, the
study did not find any effect of bed net use on the risk of
placental parasitaemia; quite possibly due to the small
number of cases found. In addition, this study found no
direct evidence that the reduced risk of LBW in bed net-
users was directly attributable to the prevention of placen-
tal malaria. This observation may also be related to low
power of the study (few mothers had placental parasitae-
mia) and the fact that placental malaria infections earlier
in pregnancy may have been cleared by the time of deliv-
ery. Although factors such as socio-economic (SES) or
nutritional status could have contributed to the risk for
LBW, this study did not assess the contribution of those
factors.
This study reported high occurrence of bed net use among
pregnant women, which may suggest a strong awareness
of malaria in pregnancy in this specific group. In western
Kenya, for instance, it was demonstrated that women who
thought malaria in pregnancy caused foetal problems
were more likely to have used an ITN[17]. The use of mos-
quito bed nets in pregnancy in Ifakara reflects the high
level coverage achieved after many years of an intense
social marketing programme and the availability of highly
subsidized ITNs since 1996[10]. These results support the
efforts of the malaria in pregnancy community to advo-
cate for full implementation of IPTp, even in the face of
other malaria control interventions.
Conclusion
The observed incidence of LBW and prevalence of placen-
tal parasitaemia at delivery suggest that malaria remains a
problem in pregnancy, even in areas with high bed net
coverage for women who do not receive IPTp. Delivery of
IPTp should be emphasized at all levels of implementa-
tion to achieve maximum community coverage.
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